Aaron F J Iding, Vincent Ten Cate, Hugo Ten Cate, Philipp S Wild, Arina J Ten Cate-Hoek
{"title":"使用无监督机器学习解开血栓后综合征的缠结概况。","authors":"Aaron F J Iding, Vincent Ten Cate, Hugo Ten Cate, Philipp S Wild, Arina J Ten Cate-Hoek","doi":"10.1182/bloodadvances.2025015829","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Postthrombotic syndrome (PTS) is a chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to investigate the heterogeneity of PTS among patients and within the Villalta scale. In 818 patients from the IDEAL DVT study, clustering identified 4 clinical profiles: (1) younger patients with provoked DVT, (2) women with joint pain, (3) men with isolated popliteal DVT, and (4) older men with diabetes and femoral vein involvement. Clustering of Villalta items revealed a distinction between signs and symptoms. Sign scores increased with older age, male sex, higher body mass index (BMI), and DVT extent, whereas symptom scores increased with younger age, female sex, higher BMI, and provoked DVT. Residual venous obstruction was significantly associated with the sign score (odds ratio, 1.18 per point) but not the symptom score. Quality of life was related to the symptom score more than the sign score. At 6 months, sign and symptom scores differed significantly across profiles, especially between profile 1 and 4, because the former had most symptoms (41% vs 21% ≥ 3; P < .001), whereas the latter had most signs (18% vs 34% ≥ 3; P = .004]). After 2 years, symptoms decreased in profile 1 but increased in profile 4. Other profiles showed intermediate scores over time. These findings suggest that reappraising the PTS scoring system to distinguish its dimensions would enable more personalized risk prediction and prevention. This trial was registered at www.ClinicalTrials.gov as #NCT01429714.</p>","PeriodicalId":9228,"journal":{"name":"Blood advances","volume":" ","pages":"3631-3641"},"PeriodicalIF":7.4000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Untangling profiles of postthrombotic syndrome using unsupervised machine learning.\",\"authors\":\"Aaron F J Iding, Vincent Ten Cate, Hugo Ten Cate, Philipp S Wild, Arina J Ten Cate-Hoek\",\"doi\":\"10.1182/bloodadvances.2025015829\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Abstract: </strong>Postthrombotic syndrome (PTS) is a chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to investigate the heterogeneity of PTS among patients and within the Villalta scale. In 818 patients from the IDEAL DVT study, clustering identified 4 clinical profiles: (1) younger patients with provoked DVT, (2) women with joint pain, (3) men with isolated popliteal DVT, and (4) older men with diabetes and femoral vein involvement. Clustering of Villalta items revealed a distinction between signs and symptoms. Sign scores increased with older age, male sex, higher body mass index (BMI), and DVT extent, whereas symptom scores increased with younger age, female sex, higher BMI, and provoked DVT. Residual venous obstruction was significantly associated with the sign score (odds ratio, 1.18 per point) but not the symptom score. Quality of life was related to the symptom score more than the sign score. At 6 months, sign and symptom scores differed significantly across profiles, especially between profile 1 and 4, because the former had most symptoms (41% vs 21% ≥ 3; P < .001), whereas the latter had most signs (18% vs 34% ≥ 3; P = .004]). After 2 years, symptoms decreased in profile 1 but increased in profile 4. Other profiles showed intermediate scores over time. These findings suggest that reappraising the PTS scoring system to distinguish its dimensions would enable more personalized risk prediction and prevention. This trial was registered at www.ClinicalTrials.gov as #NCT01429714.</p>\",\"PeriodicalId\":9228,\"journal\":{\"name\":\"Blood advances\",\"volume\":\" \",\"pages\":\"3631-3641\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood advances\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1182/bloodadvances.2025015829\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/bloodadvances.2025015829","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Untangling profiles of postthrombotic syndrome using unsupervised machine learning.
Abstract: Postthrombotic syndrome (PTS) is a chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to investigate the heterogeneity of PTS among patients and within the Villalta scale. In 818 patients from the IDEAL DVT study, clustering identified 4 clinical profiles: (1) younger patients with provoked DVT, (2) women with joint pain, (3) men with isolated popliteal DVT, and (4) older men with diabetes and femoral vein involvement. Clustering of Villalta items revealed a distinction between signs and symptoms. Sign scores increased with older age, male sex, higher body mass index (BMI), and DVT extent, whereas symptom scores increased with younger age, female sex, higher BMI, and provoked DVT. Residual venous obstruction was significantly associated with the sign score (odds ratio, 1.18 per point) but not the symptom score. Quality of life was related to the symptom score more than the sign score. At 6 months, sign and symptom scores differed significantly across profiles, especially between profile 1 and 4, because the former had most symptoms (41% vs 21% ≥ 3; P < .001), whereas the latter had most signs (18% vs 34% ≥ 3; P = .004]). After 2 years, symptoms decreased in profile 1 but increased in profile 4. Other profiles showed intermediate scores over time. These findings suggest that reappraising the PTS scoring system to distinguish its dimensions would enable more personalized risk prediction and prevention. This trial was registered at www.ClinicalTrials.gov as #NCT01429714.
期刊介绍:
Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016.
Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.